CCND1 and breast cancer: To determine the prognostic significance of PAK1 in breast cancer, gene amplification was correlated with clinical outcome using a Cox proportional hazard model constructed with METABRIC censored survival data, patient age, NPI [22], PAM50 breast cancer subtype classification, and CCND1/PAK1 amplification status.